ANDA 80504, held by Belmora LLC. Lidocaine Hydrochloride, Epinephrine; Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 80504 (Lidocaine Hydrochloride, Lidocaine Hydrochloride And Epinephrine), held by Belmora LLC, was first approved by FDA on Feb 23, 1972, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 23, 1972 | Original application | Approved | None posted |
| Lidocaine Hydrochloride2% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Lidocaine Hydrochloride And Epinephrine0.01MG/ML;2% · injectable;injection | Epinephrine; Lidocaine Hydrochloride | Discontinued |
| Lidocaine Hydrochloride And Epinephrine0.02MG/ML;2% · injectable;injection | Epinephrine; Lidocaine Hydrochloride | Discontinued |
| Oct 1, 1992 | Supplement 34Labeling | Approved | None posted |
| Oct 11, 1989 | Supplement 33Labeling | Approved | None posted |
| Nov 8, 1988 | Supplement 32Manufacturing | Approved | None posted |
| Jun 23, 1988 | Supplement 31Manufacturing | Approved | None posted |
| Jan 23, 1987 | Supplement 29Manufacturing | Approved | None posted |
| Sep 9, 1985 | Supplement 23Manufacturing | Approved | None posted |
| Sep 9, 1985 | Supplement 24Manufacturing | Approved | None posted |
| Oct 19, 1983 | Supplement 21Manufacturing | Approved | None posted |
| Feb 23, 1972 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters